{
  "id": 9677622,
  "title": "Mineralys Therapeutics director sells $3 million in shares",
  "url": "https://urgent.news/2026/09/25/mineralys-therapeutics-director-sells-3-million-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T02:01:02.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/mineralys-therapeutics-director-sells-3-million-in-shares-93CH-4916530"
  },
  "original_language": "en",
  "account": "Brian Taylor Slingsby, a director at Mineralys Therapeutics, Inc., sold 104,320 shares of common stock, indirectly attributed to him by Catalys Pacific Fund, LP. The transaction, valued at approximately $3,005,302, took place on September 22, 2026, with the shares traded at a weighted-average price of $28.8085. The stock has since lost value, currently trading at $26.59, marking a year-to-date decline of about 27%. Despite this, four analysts have recently revised their earnings forecasts upwards for the upcoming period. Following the sale, Mr. Slingsby is reported to indirectly own 7,805,718 shares through Catalys Pacific Fund, LP, though he disclaims beneficial ownership except for his pecuniary interest. As managing partner of Catalys Pacific, LLC, Mr. Slingsby may share voting and investment power over these shares. Mineralys Therapeutics recently reported a larger-than-expected loss for Q2 2026, with an adjusted loss of $2.85 per share, exceeding the estimated $2.63 loss. This increase in spending is attributed to preparations for the potential launch of their blood pressure drug, lorundrostat. The company’s financial results have ignited discussions about its future strategies and potential market impact.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Tango Therapeutics principal accounting officer sells $198k in stock",
        "url": "https://urgent.news/2026/09/25/tango-therapeutics-principal-accounting-officer-sells-198k-in-stock",
        "published": "2026-09-25T00:31:35.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}